Finance

Lists
1681:HKG
Consun Pharmaceutical Group Ltd
15,68 HK$
+1,88%
(+0,29) 1D
16 հոկ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1681...
Open
15,39 HK$
High
15,84 HK$
Low
15,38 HK$
Mkt. cap
13,14 մլրդ
Avg. vol.
1,48 մլն
Volume
1,35 մլն
Dividend
4,97%
Quarterly dividend
0,19 HK$
Ex-dividend date
08 սեպ, 2026 թ.
P/E ratio
9,68
52-wk high
19,49 HK$
52-wk low
12,31 HK$
EPS
1,62 HK$
Shares outstanding
875,19 մլն
No. of employees
3 հզր
Open
15,39 HK$
High
15,84 HK$
Low
15,38 HK$
Mkt. cap
13,14 մլրդ
Avg. vol.
1,48 մլն
Volume
1,35 մլն
Dividend
4,97%
Quarterly dividend
0,19 HK$
Ex-dividend date
08 սեպ, 2026 թ.
P/E ratio
9,68
52-wk high
19,49 HK$
52-wk low
12,31 HK$
EPS
1,62 HK$
Shares outstanding
875,19 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
About Consun Pharmaceutical Group Ltd
CEO-
Employees2,85 հզր
Founded1997
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
924,38 մլն
924,38 մլն
892,34 մլն
892,34 մլն
Cost of goods sold
195,16 մլն
195,16 մլն
166,31 մլն
166,31 մլն
Cost of revenue
195,16 մլն
195,16 մլն
166,31 մլն
166,31 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
412,59 մլն
412,59 մլն
398,41 մլն
398,41 մլն
Operating expense
410,59 մլն
410,59 մլն
394,20 մլն
394,20 մլն
Total operating expenses
605,75 մլն
605,75 մլն
560,51 մլն
560,51 մլն
Operating income
318,63 մլն
318,63 մլն
331,83 մլն
331,83 մլն
Other non operating income
-
-
-
-
EBT including unusual items
330,59 մլն
330,59 մլն
349,17 մլն
349,17 մլն
EBT excluding unusual items
331,38 մլն
331,38 մլն
349,76 մլն
349,76 մլն
Income tax expense
37,45 մլն
37,45 մլն
50,10 մլն
50,10 մլն
Effective tax rate
11,33%
11,33%
14,35%
14,35%
Other operating expenses
-1,19 մլն
-1,19 մլն
-5,01 մլն
-5,01 մլն
Net income
289,88 մլն
289,88 մլն
297,65 մլն
297,65 մլն
Net profit margin
31,36%
31,36%
33,36%
33,36%
Earnings per share
-
-
-
-
Interest and investment income
21,11 մլն
21,11 մլն
20,36 մլն
20,36 մլն
Interest expense
-946,00 հզր
-946,00 հզր
-1,34 մլն
-1,34 մլն
Net interest expenses
20,16 մլն
20,16 մլն
19,01 մլն
19,01 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
332,28 մլն
332,28 մլն
346,72 մլն
346,72 մլն
Gain or loss from assets sale
965,50 հզր
965,50 հզր
-
-
AI content may include mistakes. Learn more
Google Apps